Invesco Ltd. - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$29,804
-14.0%
20,697
+48.6%
0.00%
Q2 2023$34,673
+0.2%
13,925
+7.8%
0.00%
Q1 2023$34,612
-42.7%
12,915
+16.1%
0.00%
Q4 2022$60,409
-95.7%
11,125
-90.2%
0.00%
Q3 2022$1,412,000
+1057.4%
113,061
+601.9%
0.00%
Q1 2022$122,000
-51.6%
16,108
-34.7%
0.00%
Q4 2021$252,000
-30.4%
24,669
-8.4%
0.00%
Q3 2021$362,000
-31.8%
26,930
+11.2%
0.00%
Q2 2021$531,000
+20.4%
24,214
+32.3%
0.00%
Q1 2021$441,000
-96.4%
18,307
-97.3%
0.00%
-100.0%
Q4 2020$12,152,000
+221.1%
675,480
+106.2%
0.00%
+300.0%
Q3 2020$3,784,000
-35.8%
327,584
+34.9%
0.00%
-50.0%
Q2 2020$5,893,000
+98.4%
242,906
-9.9%
0.00%
+100.0%
Q1 2020$2,971,000
-51.6%
269,582
+16.0%
0.00%
-50.0%
Q4 2019$6,142,000
+9.1%
232,412
-6.0%
0.00%
+100.0%
Q3 2019$5,632,000
+365.8%
247,212
+527.1%
0.00%
Q2 2019$1,209,000
+3.4%
39,422
-44.0%
0.00%
Q1 2019$1,169,000
+84.4%
70,423
+112.7%
0.00%
Q4 2018$634,000
-91.3%
33,116
-76.1%
0.00%
-100.0%
Q3 2018$7,248,000
+240.6%
138,605
+183.0%
0.00%
+100.0%
Q2 2018$2,128,00048,9720.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders